Regentatlantic Capital LLC Zoetis Inc. Transaction History
Regentatlantic Capital LLC
- $3.34 Billion
- Q3 2022
A detailed history of Regentatlantic Capital LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Regentatlantic Capital LLC holds 30,740 shares of ZTS stock, worth $5.05 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
30,740
Previous 14,699
109.13%
Holding current value
$5.05 Million
Previous $2.53 Million
80.37%
% of portfolio
0.14%
Previous 0.08%
Shares
10 transactions
Others Institutions Holding ZTS
# of Institutions
1,957Shares Held
410MCall Options Held
1.02MPut Options Held
1.09M-
Vanguard Group Inc Valley Forge, PA41.2MShares$6.78 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$6.05 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.8MShares$3.25 Billion0.16% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL16MShares$2.63 Billion2.73% of portfolio
-
Alliancebernstein L.P. New York, NY15.4MShares$2.53 Billion1.05% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $76.9B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...